Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight: Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 6031 - 6040 of 6045 results

First page
Previous page
604
Next page
Next page

INFLUENZA A VIRUS A/MICHIGAN/45/2015 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

69H0YJ871T

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce88cc84-b4ed-4d59-8897-10cb53dc2edf

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce88cc84-b4ed-4d59-8897-10cb53dc2edf

Class:

CONCEPT

INFLUENZA A VIRUS A/HONG KONG/4801/2014 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

2I1EOL437M

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fc8b76d7-97c4-4d1f-b96a-5cdb86edf40f

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fc8b76d7-97c4-4d1f-b96a-5cdb86edf40f

Class:

CONCEPT

INFLUENZA A VIRUS A/VICTORIA/361/2011 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

K5313H4VGS

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529

Class:

CONCEPT

INFLUENZA B VIRUS B/BRISBANE/60/2008 RECOMBINANT HEMAGGLUTININ ANTIGEN

058U2312CR

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce88cc84-b4ed-4d59-8897-10cb53dc2edf

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce88cc84-b4ed-4d59-8897-10cb53dc2edf

Class:

CONCEPT

INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 RECOMBINANT HEMAGGLUTININ ANTIGEN

AYR0WZX7JH

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb2aad7e-82d2-47c0-9eb3-08ac62641a47

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb2aad7e-82d2-47c0-9eb3-08ac62641a47

Class:

CONCEPT

INFLUENZA B VIRUS B/WISCONSIN/1/2010 RECOMBINANT HEMAGGLUTININ ANTIGEN

N9C76986U2

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529

Class:

CONCEPT

INFLUENZA A VIRUS A/TEXAS/50/2012 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

1IQZ1WCE3Y

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb2aad7e-82d2-47c0-9eb3-08ac62641a47

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb2aad7e-82d2-47c0-9eb3-08ac62641a47

Class:

CONCEPT

INFLUENZA A VIRUS A/CALIFORNIA/7/2009 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

1SE9Z7D2QR

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529

Class:

CONCEPT

HAEMOPHILUS INFLUENZAE TYPE B STRAIN 20752 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN

C9R35M8XV6

Status:

Possibly Marketed Outside US

Source:

BLA125347

(2009)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=745ff8df-1618-4b76-9aa1-6f42752c0dda

First approved in 2009

Source:

BLA125347

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=745ff8df-1618-4b76-9aa1-6f42752c0dda

Class:

CONCEPT

BORDETELLA PERTUSSIS PERTACTIN ANTIGEN

63GD90PP8X

Status:

Possibly Marketed Outside US

Source:

Canada:PERTACTIN

Source URL:

https://tripod.nih.gov/npc/#Download

First approved in 2002

Source:

BLA103666

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06f34d0f-4e72-41d3-967f-8abf3f2005c1

Class:

CONCEPT

Concept

INFLUENZA A VIRUS A/MICHIGAN/45/2015 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA A VIRUS A/HONG KONG/4801/2014 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA A VIRUS A/VICTORIA/361/2011 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA B VIRUS B/BRISBANE/60/2008 RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA B VIRUS B/WISCONSIN/1/2010 RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA A VIRUS A/TEXAS/50/2012 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA A VIRUS A/CALIFORNIA/7/2009 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

HAEMOPHILUS INFLUENZAE TYPE B STRAIN 20752 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN

Concept

BORDETELLA PERTUSSIS PERTACTIN ANTIGEN

Showing 6031 - 6040 of 6045 results

First page
Previous page
604
Next page
Next page

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1